AWA
MRK icon

ARS Wealth Advisors’s Merck MRK Stock Holding History

ARS Wealth Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$7.47M Buy
96,074
+2,083
+2% +$155K 1.34% 22
2021
Q1 		$6.91M Buy
93,991
+20,611
+28% +$1.52M 1.51% 21
2020
Q4 		$5.73M Buy
73,380
+7,617
+12% +$583K 1.23% 21
2020
Q3 		$5.21M Buy
65,763
+4,165
+7% +$326K 1.43% 15
2020
Q2 		$4.54M Buy
61,598
+1,365
+2% +$103K 1.42% 14
2020
Q1 		$4.42M Sell
60,233
-2,296
-4% -$180K 1.86% 11
2019
Q4 		$5.43M Buy
62,529
+1,353
+2% +$111K 1.57% 12
2019
Q3 		$4.91M Sell
61,176
-2,848
-4% -$228K 1.56% 12
2019
Q2 		$5.12M Buy
64,024
+2,783
+5% +$213K 1.63% 12
2019
Q1 		$4.86M Buy
61,241
+364
+0.6% +$27.2K 1.55% 12
2018
Q4 		$4.44M Buy
60,877
+2,151
+4% +$152K 1.62% 11
2018
Q3 		$3.98M Buy
58,726
+4,176
+8% +$266K 1.33% 15
2018
Q2 		$3.16M Buy
54,550
+3,988
+8% +$225K 1.14% 16
2018
Q1 		$2.63M Buy
50,562
+843
+2% +$45.5K 0.98% 19
2017
Q4 		$2.67M Sell
49,719
-322
-0.6% -$17.9K 0.99% 22
2017
Q3 		$3.06M Sell
50,041
-1,554
-3% -$94.2K 1.19% 19
2017
Q2 		$3.15M Buy
51,595
+68
+0.1% +$4.14K 1.28% 15
2017
Q1 		$3.12M Buy
51,527
+1,414
+3% +$85.8K 1.34% 16
2016
Q4 		$2.81M Sell
50,113
-467
-0.9% -$27.3K 1.26% 15
2016
Q3 		$3.01M Buy
50,580
+5,184
+11% +$303K 1.28% 16
2016
Q2 		$2.5M Buy
45,396
+8,675
+24% +$462K 1.06% 19
2016
Q1 		$1.85M Buy
36,721
+4,133
+13% +$202K 0.87% 19
2015
Q4 		$1.64M Buy
32,588
+23,940
+277% +$1.21M 0.85% 18
2015
Q3 		$408K Sell
8,648
-137
-2% -$7.28K 0.21% 43
2015
Q2 		$477K Buy
8,785
+271
+3% +$15.2K 0.21% 38
2015
Q1 		$467K Buy
8,514
+188
+2% +$10.6K 0.2% 39
2014
Q4 		$451K Sell
8,326
-264
-3% -$14.7K 0.2% 42
2014
Q3 		$486K Hold
8,590
– – 0.23% 36
2014
Q2 		$474K Buy
+8,590
New +$469K 0.23% 36

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ARS Wealth Advisors's MRK Position: Q2 2021 in Review

ARS Wealth Advisors increased its Merck (MRK) stake by 2.2% in Q2 2021, buying an estimated $155K and bringing the position to 96,074 shares worth $7.47M. The position accounts for 1.34% of the portfolio, ranked #22.

ARS Wealth Advisors first reported a position in MRK in Q2 2014 and has held it in 29 quarters since. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • ARS Wealth Advisors held 96,074 shares of Merck worth $7.47M as of Q2 2021.
  • ARS Wealth Advisors bought 2,083 Merck shares in Q2 2021, an estimated $155K.
  • Merck made up 1.34% of ARS Wealth Advisors's portfolio in Q2 2021, its #22 holding.
  • ARS Wealth Advisors first reported a position in Merck in Q2 2014 and has held it in 29 quarters since.
  • 2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on ARS Wealth Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.